当前位置: X-MOL 学术Blood › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib.
Blood ( IF 20.3 ) Pub Date : 2022-04-07 , DOI: 10.1182/blood.2021013926
Noelia Purroy 1, 2, 3 , Yuzhou Evelyn Tong 2, 3, 4 , Camilla K Lemvigh 1, 5 , Nicoletta Cieri 1, 2, 3 , Shuqiang Li 3, 6 , Erin M Parry 1, 2, 3 , Wandi Zhang 1 , Laura Z Rassenti 7 , Thomas J Kipps 7 , Susan L Slager 8 , Neil E Kay 8, 9 , Connie Lesnick 9 , Tait D Shanafelt 10 , Paolo Ghia 11 , Lydia Scarfò 11 , Kenneth J Livak 1, 6 , Peter V Kharchenko 12 , Donna S Neuberg 13 , Lars Rønn Olsen 4, 5 , Jean Fan 14 , Satyen H Gohil 1, 2, 3, 15 , Catherine J Wu 1, 2, 3, 16
Affiliation  



中文翻译:

单细胞分析揭示了 CLL 早期阶段的免疫功能障碍,可以通过依鲁替尼逆转。

更新日期:2022-01-12
down
wechat
bug